相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Nonsense-Mediated RNA Decay by the Tumor Microenvironment Promotes Tumorigenesis
Ding Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation
Sebastien Apcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
NMD: RNA biology meets human genetic medicine
Madhuri Bhuvanagiri et al.
BIOCHEMICAL JOURNAL (2010)
Execution of nonsense-mediated mRNA decay: what defines a substrate?
Indrani Rebbapragada et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells
Soraya Chaouch et al.
HUMAN GENE THERAPY (2009)
Enhanced Exon-skipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy
Aurelie Goyenvalle et al.
MOLECULAR THERAPY (2009)
A UPF3-mediated regulatory switch that maintains RNA surveillance
Wai-Kin Chan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial
Wenxia Meng et al.
TRIALS (2009)
Recognition and elimination of nonsense mRNA
Oliver Muhlemann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies
Sebastien Durand et al.
JOURNAL OF CELL BIOLOGY (2007)
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function
Olaf Isken et al.
GENES & DEVELOPMENT (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements
Liana F. Lareau et al.
NATURE (2007)
Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay
Julie Z. Ni et al.
GENES & DEVELOPMENT (2007)
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Liat Linde et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene-expression variation within and among human populations
John D. Storey et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
Marcelo H. Viegas et al.
NUCLEIC ACIDS RESEARCH (2007)
Nonsense-mediated mRNA decay: target genes and functional diversification of effectors
Jan Rehwinkel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Exogenous control of mammalian gene expression via modulation of translational termination
George J. Murphy et al.
NATURE MEDICINE (2006)
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Holly A. Kuzmiak et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation
Joachim B. Kunz et al.
RNA (2006)
Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements
NH Gehring et al.
MOLECULAR CELL (2005)
DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome
LS Correa-Cerro et al.
JOURNAL OF MEDICAL GENETICS (2005)
Characterization of novel airway submucosal gland cell models for cystic fibrosis studies
AC da Paula et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2005)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex
SY Chin et al.
GENES & DEVELOPMENT (2004)
The major 5 ' determinant in stop codon read-through involves two adjacent adenines
S Tork et al.
NUCLEIC ACIDS RESEARCH (2004)
Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20
Y Ishigaki et al.
CELL (2001)
Impact of the six nucleotides downstream of the stop codon on translation termination
O Namy et al.
EMBO REPORTS (2001)
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs
A Sureau et al.
EMBO JOURNAL (2001)
Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon
J Lykke-Andersen et al.
CELL (2000)
Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain
GE Crawford et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
